Lamivudine 150 MG Zidovudine 300 MG Oral Tablet

1 INDICATIONS AND USAGE Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogue reverse transcriptase inhibitors, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

Mylan Pharmaceuticals Inc.

FDA Reported Adverse Reactions
`[1] off label use` `[2] nausea` `[3] drug ineffective` `[4] fatigue` `[5] diarrhoea` `[6] pain` `[7] vomiting` `[8] dyspnoea` `[9] pyrexia` `[10] headache`

4 years ago

OVAL WHITE L Z M 1

16 HOW SUPPLIED/STORAGE AND HANDLING Lamivudine and Zidovudine Tablets, USP are available containing 150 mg of lamivudine, USP and 300 mg of zidovudine, USP. The 150 mg/300 mg tablets are white to off-white, film-coated, capsule shaped, scored tablets debossed with L on the left of the score and Z on the right of the score on one side of the tablet and M on the left of the score and 1 on the right of the score on the other side. They are available as follows: NDC 0378-5180-91 bottle of 60 tablets Store between 2° and 30°C (36° and 86°F). Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.

More pills like OVAL L Z M 1

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Lamivudine 150 MG Zidovudine 300 MG Oral Tablet

FDA Reported Adverse Reactions [1] off label use [2] nausea [3] drug ineffective [4] fatigue [5] diarrhoea [6] pain [7] vomiting [8] dyspnoea [9] pyrexia [10] headache

OVAL WHITE L Z M 1

More pills like OVAL L Z M 1

FDA Reported Adverse Reactions
`[1] off label use` `[2] nausea` `[3] drug ineffective` `[4] fatigue` `[5] diarrhoea` `[6] pain` `[7] vomiting` `[8] dyspnoea` `[9] pyrexia` `[10] headache`